Company Name: DBV Technologies S.A.
DBV Technologies S.A. is a clinical stage specialty biopharmaceutical company. The company is focused on the development and commercialization of treatments for food and pediatric allergies. The company’s lead product candidate is a treatment for peanut allergies.
Ticker Symbol: DBVT (NASDAQ)
Company Website: www.dbv-technologies.com
Headquarters: Bagneux, France